These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2337981)

  • 1. Effects of methylamine and heparin on a rapid chromogenic assay of C1-esterase inhibitor in plasma.
    Munkvad S; Jespersen J; Gram J; Overgaard K; Rånby M
    Clin Chem; 1990 May; 36(5):737-41. PubMed ID: 2337981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new simple method for determination of C1-esterase inhibitor activity in plasma.
    Wiman B; Nilsson T
    Clin Chim Acta; 1983 Mar; 128(2-3):359-66. PubMed ID: 6602012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific, sensitive, precise, and rapid functional chromogenic assay of activated first complement component (C1) in plasma.
    Munkvad S; Jespersen J; Sidelmann J; Gram J
    Clin Chem; 1990 Jul; 36(7):1305-11. PubMed ID: 2372942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.
    Wijeyewickrema LC; Lameignere E; Hor L; Duncan RC; Shiba T; Travers RJ; Kapopara PR; Lei V; Smith SA; Kim H; Morrissey JH; Pike RN; Conway EM
    Blood; 2016 Sep; 128(13):1766-76. PubMed ID: 27338096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of C1-esterase inhibitor by heparin and interactions with C1s protease as assessed by surface plasmon resonance.
    Rajabi M; Struble E; Zhou Z; Karnaukhova E
    Biochim Biophys Acta; 2012 Jan; 1820(1):56-63. PubMed ID: 22040724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New and rapid functional assay for C1 inhibitor in human plasma.
    Schapira M; Silver LD; Scott CF; Colman RW
    Blood; 1982 Apr; 59(4):719-24. PubMed ID: 6174161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma C1 inhibitor in malignant diseases: functional activity versus concentration.
    Starcević D; Jelić-Ivanović Z; Kalimanovska V
    Ann Clin Biochem; 1991 Nov; 28 ( Pt 6)():595-8. PubMed ID: 1776810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1 inhibitor and diagnosis of hereditary angioedema in newborns.
    Nielsen EW; Johansen HT; Holt J; Mollnes TE
    Pediatr Res; 1994 Feb; 35(2):184-7. PubMed ID: 8165053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma.
    Schapira M; Scott CF; Colman RW
    J Clin Invest; 1982 Feb; 69(2):462-8. PubMed ID: 6173399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model.
    Bos IG; van Mierlo GJ; Bleeker WK; Rigter GM; te Velthuis H; Dickneite G; Hack CE
    Int Immunopharmacol; 2001 Aug; 1(8):1583-95. PubMed ID: 11515821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1).
    Windfuhr JP; Alsenz J; Loos M
    Mol Immunol; 2005 Apr; 42(6):657-63. PubMed ID: 15781109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive method to assay blood complement C1- inhibitor activity.
    Drouet C; Alibeu C; Ponard D; Arlaud GJ; Colomb MG
    Clin Chim Acta; 1988 May; 174(2):121-30. PubMed ID: 3260154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in purified dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies.
    Donaldson VH; Harrison RA; Rosen FS; Bing DH; Kindness G; Canar J; Wagner CJ; Awad S
    J Clin Invest; 1985 Jan; 75(1):124-32. PubMed ID: 3965500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and function of C1 inhibitor.
    Davis AE
    Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro interaction of C1-inhibitor with thrombin.
    Cugno M; Bos I; Lubbers Y; Hack CE; Agostoni A
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):253-60. PubMed ID: 11460008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELISA to measure neutralizing capacity of anti-C1-inhibitor antibodies in plasma of angioedema patients.
    Engel R; Rensink I; Roem D; Brouwer M; Kalei A; Perry D; Zeerleder S; Wouters D; Hamann D
    J Immunol Methods; 2015 Nov; 426():114-9. PubMed ID: 26318839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.
    Prandini MH; Reboul A; Colomb MG
    Biochem J; 1986 Jul; 237(1):93-8. PubMed ID: 3099750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of anti-C1-inhibitor autoantibodies: prevention of the formation of stable C1s-C1-inh complexes.
    He S; Sim RB; Whaley K
    Mol Med; 1998 Feb; 4(2):119-28. PubMed ID: 9508789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional determination of C1 esterase inhibitor in fractions derived from plasma.
    Benny AG; Brimer CM
    Haematologia (Budap); 1989; 22(3):189-93. PubMed ID: 2583599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.